- CEO, MedeAnalytics
Andy Hurd joined Mede Analytics in May 2013 as chief executive officer, bringing with him over 25 years of experience in healthcare IT, including product and market innovation as well as strategic partnerships.
Most recently, Andy was CEO of Epocrates (NASDAQ: EPOC),which was purchased by athenahealth (NASDAQ: ATHN). Prior to Epocrates, Andyserved as chairman and CEO of Carefx, which was acquired by Harris Corporation (NYSE: HRS) in 2011. During his six-year tenure at Carefx, the company achievedstrong growth in revenue, income and shareholder value. Before Carefx, Hurdheld senior management positions at WebMD, LLC (NASDAQ: WBMD) and QuadraMed Corporation.
Andy holds a bachelor’s degree in business administration from Northern Arizona University, and he is a member of the board of directors of Ability Networks and the Cleveland Clinic Innovations Advisory Board.Back to Innovation Advisory Board